These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35804418)

  • 1. Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats.
    Chou WC; Cheng YH; Riviere JE; Monteiro-Riviere NA; Kreyling WG; Lin Z
    Part Fibre Toxicol; 2022 Jul; 19(1):47. PubMed ID: 35804418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles.
    Deng L; Liu H; Ma Y; Miao Y; Fu X; Deng Q
    Toxicol Appl Pharmacol; 2019 Dec; 384():114765. PubMed ID: 31669777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice.
    Lin Z; Monteiro-Riviere NA; Riviere JE
    Nanotoxicology; 2016; 10(2):162-72. PubMed ID: 25961857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.
    Cheng YH; Riviere JE; Monteiro-Riviere NA; Lin Z
    Nanotoxicology; 2018 Jun; 12(5):453-469. PubMed ID: 29658401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles.
    Carlander U; Li D; Jolliet O; Emond C; Johanson G
    Int J Nanomedicine; 2016; 11():625-40. PubMed ID: 26929620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based pharmacokinetic modeling of nanoceria systemic distribution in rats suggests dose- and route-dependent biokinetics.
    Carlander U; Moto TP; Desalegn AA; Yokel RA; Johanson G
    Int J Nanomedicine; 2018; 13():2631-2646. PubMed ID: 29750034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation.
    Aborig M; Malik PRV; Nambiar S; Chelle P; Darko J; Mutsaers A; Edginton AN; Fleck A; Osei E; Wettig S
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 31013763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice.
    Chou WC; Chen Q; Yuan L; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE; Lin Z
    J Control Release; 2023 Sep; 361():53-63. PubMed ID: 37499908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
    Chou WC; Lin Z
    Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling.
    Lin Z; Aryal S; Cheng YH; Gesquiere AJ
    ACS Nano; 2022 Dec; 16(12):19722-19754. PubMed ID: 36520546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling of Nanomaterials.
    Ozbek O; Genc DE; O Ulgen K
    ACS Pharmacol Transl Sci; 2024 Aug; 7(8):2251-2279. PubMed ID: 39144562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of
    Clewell HJ; Campbell JL; Van Landingham C; Franzen A; Yoon M; Dodd DE; Andersen ME; Gentry PR
    Inhal Toxicol; 2019; 31(13-14):468-483. PubMed ID: 31992090
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance Assessment and Translation of Physiologically Based Pharmacokinetic Models From acslX to Berkeley Madonna, MATLAB, and R Language: Oxytetracycline and Gold Nanoparticles As Case Examples.
    Lin Z; Jaberi-Douraki M; He C; Jin S; Yang RSH; Fisher JW; Riviere JE
    Toxicol Sci; 2017 Jul; 158(1):23-35. PubMed ID: 28402537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the biodistribution of inhaled gold nanoparticles in rats with interspecies extrapolation to humans.
    Gakis GP; Krikas A; Neofytou P; Tran L; Charitidis C
    Toxicol Appl Pharmacol; 2022 Dec; 457():116322. PubMed ID: 36414120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments.
    Bachler G; Losert S; Umehara Y; von Goetz N; Rodriguez-Lorenzo L; Petri-Fink A; Rothen-Rutishauser B; Hungerbuehler K
    Part Fibre Toxicol; 2015 Jun; 12():18. PubMed ID: 26116549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physiologically based pharmacokinetic model to predict pegylated liposomal doxorubicin disposition in rats and human.
    Montanha MC; Howarth A; Mohamed DA; Loier E; Main L; Rösslein M; Delmaar C; Prina-Mello A; Siccardi M
    Drug Deliv Transl Res; 2022 Sep; 12(9):2178-2186. PubMed ID: 35551629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter.
    Zhang L; Su H; Wang H; Li Q; Li X; Zhou C; Xu J; Chai Y; Liang X; Xiong L; Zhang C
    Theranostics; 2019; 9(7):1893-1908. PubMed ID: 31037146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of clearance, retention, and translocation of inhaled gold nanoparticles in rats.
    Krikas A; Neofytou P; Gakis GP; Xiarchos I; Charitidis C; Tran L
    Inhal Toxicol; 2022; 34(13-14):361-379. PubMed ID: 36053230
    [No Abstract]   [Full Text] [Related]  

  • 20. Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution.
    Zazo H; Colino CI; Gutiérrez-Millán C; Cordero AA; Bartneck M; Lanao JM
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.